A phase II study of FOLFOXIRI plus panitumumab followed by evaluation for resection in patients with metastatic kras wild-type colorectal cancer with liver metastases only

The Oncologist

from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/1RJv4hR
via IFTTT